Skin Cancer

Melanoma of the Trunk

Female, 56 years

Patient Internal ID: 801207744

ICD-10 code

C43.5 Malignant Melanoma of Trunk

Diagnosis (Incl. Metastases/Stage) and Year

April 2021
In 2015 the patient was diagnosed with Stage 2 Melanoma. After resection, no further treatment was required.
In 2021 diagnosis – Cutaneous Melanoma Anterior Chest Wall) pTxN1M1 BRAF V600(+) Stage IV, Multiple Metastases to Lungs, Subcutaneous Tissue, Neck, and Mediastinal Lymph Nodes.

Previous Treatment

Surgery, Target Therapy (Dabrafenib + Trametinib).

Prognosis and Survival Expectation

The prognosis remains poor, with a median survival of ~1-2 years from diagnosis.

Treatment Provided

Autologous DCV (7 doses) over a period of 8 months.

Patient Survival/Condition and Year
Date of Review: 15/11/2023

The patient has survived for 31 months. She continues active treatment with Target Therapy. It can be concluded that that the addition of Immunotherapy, alongside Surgery and Target Therapy, has extended patient survival for at least 7 months so far.

Disclaimer

We encourage you to learn more about your condition and treatment options to make informed decisions about your healthcare. However, please keep in mind that not all information available online or in other sources is accurate or relevant to your specific situation. It’s important to rely on credible, evidence-based sources such as official medical websites, peer-reviewed publications, or information provided by professional healthcare organizations. Always discuss any information you find with your healthcare provider before making decisions, as they can help clarify details, address concerns, and ensure the information is appropriate for your unique needs.

Ok